Liposome-Based Photodynamic Therapy for Breast Cancer: Innovations in Targeted Delivery, Combination Strategies, and Clinical Translation
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27114763 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Nehla Banu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Oncology, Washington University of Medical School, 660 S. Euclid Ave., St. Louis, MO 63110-1010, USA. Hauptthemen laut MEDLINE: Photochemotherapy, Breast Neoplasms, Liposomes, Photosensitizing Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer remains a leading cause of cancer-related mortality worldwide, with treatment resistance, recurrence, and metastasis significantly limiting the effectiveness of conventional therapies. Photodynamic therapy (PDT) has emerged as a minimally invasive and highly selective approach, utilizing photosensitizer-generated reactive oxygen species (ROS) to achieve precise tumor cytotoxicity while preserving surrounding healthy tissue. However, clinical translation of PDT remains constrained by critical biological barriers within the tumor microenvironment, including tumor hypoxia, limited light penetration, poor photosensitizer stability, and inefficient cellular uptake. Antigen-targeted liposomal nanocarriers offer a compelling solution by enabling targeted drug delivery and tumor-specific photosensitizer accumulation, prolonged systemic circulation, and enhanced cellular internalization. Their multifunctional architecture uniquely supports combinational therapeutic strategies, integrating PDT with chemotherapy, photothermal therapy, gene therapy, X-ray-induced photodynamic therapy (X-PDT) and immune checkpoint blockade, thereby amplifying antitumor efficacy and overcoming drug resistance mechanisms. This review comprehensively summarizes recent advances in liposome-based PDT for breast cancer, highlighting multimodal therapeutic integration. Special emphasis is placed on preclinical and emerging clinical outcomes, pilot-scale manufacturing considerations, and strategies to minimize immune clearance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Oncology, Washington University of Medical School, 660 S. Euclid Ave., St. Louis, MO 63110-1010, USA.
- Facultad de Ingenierías y Tecnologías, Universidad La Salle Bajío, León 37150, Guanajuato, Mexico.
- Centro de Física Aplicada y Tecnología Avanzada, Universidad Nacional Autónoma de México, Apartado Postal 1-1010, Santiago de Querétaro 76000, Querétaro, Mexico.
ORCID-Profile: Muhammad Azeem Saeed, Pedro Salas
Zitieren
APA
Banu, N., de la Rosa, E., Saeed, M. A., Salas, P., & Panikar, S. S. (2026). Liposome-Based Photodynamic Therapy for Breast Cancer: Innovations in Targeted Delivery, Combination Strategies, and Clinical Translation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27114763
Vancouver
Banu N, de la Rosa E, Saeed MA, Salas P, Panikar SS. Liposome-Based Photodynamic Therapy for Breast Cancer: Innovations in Targeted Delivery, Combination Strategies, and Clinical Translation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27114763
BibTeX
@article{Banu2026,
author = {Banu, Nehla and de la Rosa, Elder and Saeed, Muhammad Azeem and Salas, Pedro and Panikar, Sandeep Surendra},
title = {Liposome-Based Photodynamic Therapy for Breast Cancer: Innovations in Targeted Delivery, Combination Strategies, and Clinical Translation},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27114763}
}
EUVIMED